Double mutant heat-labile toxin (Tulane University)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDouble mutant heat-labile toxin (Tulane University)
Drug Alias NamedmLT
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsEscherichia coli Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTulane University
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Tulane University
Inactive CompaniesN/A
Active IndicationsEscherichia coli Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A